BIGBEAR
PHARMACEUTICALS
Dose escalation design for safe treatment initiation.
Synergistic combination therapy to break through survival limits.
AuthenticGuaranteeFast DeliveryPrivacy Venetoclax is an orally administered anticancer drug, with its main component being a BCL-2 inhibitor (BCL-2 is a protein that helps cancer cells survive). It is primarily used to treat specific types of leukemia. It works by directly binding to the BCL-2 protein, reactivating the suppressed "cell self-clearance switch," thereby allowing cancer cells to resume normal apoptosis (which can be understood as initiating the self-destruction program in cancer cells).
This drug needs to be used in combination with azacitidine, specifically for two categories of acute myeloid leukemia patients:
Adult patients who are unsuitable for high-intensity chemotherapy due to comorbidities such as heart disease or diabetes.
Elderly patients aged 75 and above.
Through this combination therapy regimen, it can effectively control the progression of leukemia without placing an additional burden on the body.
Special attention must be paid: Patients who are allergic to any component of this medication must not use it. Use is generally not recommended for pregnant women, nursing mothers, or children. If a doctor deems the medication necessary after evaluation, the patient's condition must be closely monitored throughout the course of treatment. If you are currently taking other medications, consult a doctor or pharmacist before starting new treatment and proactively inform them of all diagnosed medical conditions and ongoing treatment plans. Individuals who are pregnant, planning a pregnancy, or breastfeeding should be especially cautious and inform their doctor of their situation.
Special attention must be paid to drug combination issues: Do not use potent CYP3A inducers (these medications accelerate the metabolism of other drugs) or moderate CYP3A inducers concurrently with this product.
When used concomitantly with the anticoagulant warfarin, there may be an increased risk of bleeding. Close monitoring of the patient's coagulation parameters (International Normalized Ratio) is required.
Concomitant use with P-gp substrate drugs (these medications require transport proteins for metabolism) should be avoided, as it may increase the toxicity of these drugs. If concomitant use is indeed necessary, P-gp substrate drugs must be administered separately at least 6 hours before taking this product.
The medication should be stored tightly sealed in an environment not exceeding 30°C. The expiration period is 24 months for the 10 mg specification, 24 months for the 50 mg specification, and 36 months for the 100 mg specification. Use requires a doctor's guidance and regular monitoring of the condition to ensure safe and effective use. During the medication period, it is recommended to maintain a light diet and avoid spicy and irritating foods such as chili peppers and Sichuan peppercorns, as they may affect the drug's efficacy or increase the risk of side effects. If the tablets show any color change, abnormal shape, or unusual odor, discontinue use immediately. Store the medication out of reach of children.
Caution is advised for the following three groups of people, as its use may increase health risks:
Pregnant women: It may affect fetal development.
Lactating women: The medicinal components may pass into breast milk and affect infants.
Pediatric population: Clinical data on the safety and efficacy of this drug is currently lacking.
If the use of venetoclax is deemed necessary, close monitoring of the body’s response is required during the medication period. Seek immediate medical advice from a doctor if any adverse symptoms occur. For patients for whom the doctor has decided to prescribe the drug after a risk assessment, continuous monitoring of the patient’s condition throughout the treatment course and adequate preparation for emergency management are also required.
Serious adverse reactions that may occur include:
Febrile neutropenia (a sharp decrease in white blood cells accompanied by fever);
Pneumonia (Note: does not include pneumonia caused by fungal infections);
Sepsis (Note: does not include sepsis caused by fungi);
Respiratory failure (inability to maintain normal breathing independently);
Multiple organ dysfunction syndrome (simultaneous problems with multiple organs).
Gastrointestinal symptoms such as nausea, diarrhea, constipation;
Neutropenia (decreased white blood cells), thrombocytopenia (decreased clotting cells);
Bleeding tendency (e.g., gum bleeding, nosebleeds);
Limb edema, vomiting, fatigue;
Fever accompanied by leukopenia, skin rash, anemia (decreased hemoglobin).
The occurrence of adverse reactions may vary among different patients and could be related to individual constitution, medication method, and other factors. During medication, pay attention to any changes in your body. If you experience the above discomfort symptoms or any other abnormal feelings, please contact your doctor immediately. Depending on the situation, regular monitoring of basic vital signs such as blood pressure, heart rate, and respiratory rate may be necessary to obtain timely professional medical advice.
Individuals who are allergic to any ingredient of the medication are strictly prohibited from using it.
If you experience any discomfort during the medication process, please seek medical attention promptly. The doctor will assess the severity of the adverse reaction to determine whether the medication needs to be discontinued. For example, treatment may need to be terminated in cases such as persistent high fever, severe bleeding tendency, or difficulty breathing. Whether to stop the medication should be determined by a professional physician after comprehensive evaluation. Patients should not interrupt the medication on their own.
If any issues arise, please contact us immediately.
Email:haiousales@gmail.com
Copyright2024@ BIGBEAR All right reserved BIGBEAR
